Replies to post #27466 on Ariad Pharmaceuticals Inc fka ARIA

[jaybe]

How can she not raise Pona's DCF value with the prospect of 2-4 new indications now public. Isn't a new indication for Pona ahead of '113 in the pipeline? Pona will see revenue from a new indication before '113 sees any.